Zobrazeno 1 - 10
of 317
pro vyhledávání: '"Parambir S Dulai"'
Autor:
Renee E. Oles, Marvic Carrillo Terrazas, Luke R. Loomis, Chia-Yun Hsu, Caitlin Tribelhorn, Pedro Belda-Ferre, Allison C. Ea, MacKenzie Bryant, Jocelyn A. Young, Hannah C. Carrow, William J. Sandborn, Parambir S. Dulai, Mamata Sivagnanam, David Pride, Rob Knight, Hiutung Chu
Publikováno v:
mSystems, Vol 9, Iss 7 (2024)
ABSTRACT Bacteroides fragilis is a Gram-negative commensal bacterium commonly found in the human colon, which differentiates into two genomospecies termed divisions I and II. Through a comprehensive collection of 694 B. fragilis whole genome sequence
Externí odkaz:
https://doaj.org/article/cbd91d6e96364acca477a7ffa3aa8927
Autor:
Shreyas V. Kumbhare, Inti Pedroso, Bharat Joshi, Karthik M. Muthukumar, Santosh K. Saravanan, Carmel Irudayanathan, Gursimran S. Kochhar, Parambir S. Dulai, Ranjan Sinha, Daniel E. Almonacid
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
IntroductionThe gut microbiome’s influence on weight management has gained significant interest for its potential to support better obesity therapeutics. Patient stratification leading to personalized nutritional intervention has shown benefits ove
Externí odkaz:
https://doaj.org/article/4663fdaa08e14d8895e05d6fd18dfcfe
Autor:
Xingsheng Ren, Laura D. Manzanares, Enzo B. Piccolo, Jessica M. Urbanczyk, David P. Sullivan, Lenore K. Yalom, Triet M. Bui, Connor Lantz, Hinda Najem, Parambir S. Dulai, Amy B. Heimberger, Edward B. Thorp, Ronen Sumagin
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 15 (2023)
Neutrophil (PMN) mobilization to sites of insult is critical for host defense and requires transendothelial migration (TEM). TEM involves several well-studied sequential adhesive interactions with vascular endothelial cells (ECs); however, what initi
Externí odkaz:
https://doaj.org/article/8ae8d8ce502040ed92460113def273bc
Autor:
Carlos G. Gonzalez, Robert H. Mills, Qiyun Zhu, Consuelo Sauceda, Rob Knight, Parambir S. Dulai, David J. Gonzalez
Publikováno v:
Microbiome, Vol 10, Iss 1, Pp 1-15 (2022)
Abstract Background Crohn’s disease (CD), an inflammatory bowel disease (IBD) subtype, results from pathologic interactions between host cells and its resident gut microbes. CD manifests in both isolated disease locations (ileum or colon) or a comb
Externí odkaz:
https://doaj.org/article/c002634b272f4059b314465e7c609725
Autor:
Carlos G. Gonzalez, Robert H. Mills, Melissa C. Kordahi, Marvic Carrillo-Terrazas, Henry Secaira-Morocho, Christella E. Widjaja, Matthew S. Tsai, Yash Mittal, Brian A. Yee, Fernando Vargas, Kelly Weldon, Julia M. Gauglitz, Clara Delaroque, Consuelo Sauceda, Leigh-Ana Rossitto, Gail Ackermann, Gregory Humphrey, Austin D. Swafford, Corey A. Siegel, Jay C. Buckey, Jr., Laura E. Raffals, Charlotte Sadler, Peter Lindholm, Kathleen M. Fisch, Mark Valaseck, Arief Suriawinata, Gene W. Yeo, Pradipta Ghosh, John T. Chang, Hiutung Chu, Pieter Dorrestein, Qiyun Zhu, Benoit Chassaing, Rob Knight, David J. Gonzalez, Parambir S. Dulai
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 14, Iss 1, Pp 35-53 (2022)
Background & Aims: Hyperbaric oxygen therapy (HBOT) is a promising treatment for moderate-to-severe ulcerative colitis. However, our current understanding of the host and microbial response to HBOT remains unclear. This study examined the molecular m
Externí odkaz:
https://doaj.org/article/f12abfe4e4f44987a022d512ae5ef9c1
Autor:
Rahma Elmahdi, Gursimran S. Kochhar, Aske T. Iversen, Kristine H. Allin, Parambir S. Dulai, Aakash Desai, Tine Jess
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 6, Pp 1114-1121 (2022)
Background and Aims: Human immunodeficiency virus (HIV) infection is associated with several immune-mediated disorders. However, the risk of inflammatory bowel disease (IBD) in people living with HIV (PLWH) remains unclear. We aimed to assess the ris
Externí odkaz:
https://doaj.org/article/c20e15df5bfe424fb261becc2014abd4
Autor:
Consuelo Sauceda, Charlie Bayne, Khadijeh Sudqi, Antonio Gonzalez, Parambir S. Dulai, Rob Knight, David J. Gonzalez, Carlos G. Gonzalez
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
ABSTRACTInflammatory Bowel Disease (IBD) is a chronic immune-mediated inflammatory disease of the gastrointestinal tract that is a growing public burden. Gut microbes and their interactions with hosts play a crucial role in disease pathogenesis and p
Externí odkaz:
https://doaj.org/article/8643a163209c48db8c8a21913912ff60
Autor:
Shreyas V. Kumbhare, Patricia A. Francis-Lyon, Dashyanng Kachru, Tejaswini Uday, Carmel Irudayanathan, Karthik M. Muthukumar, Roshni R. Ricchetti, Simitha Singh-Rambiritch, Juan Ugalde, Parambir S. Dulai, Daniel E. Almonacid, Ranjan Sinha
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Diet and lifestyle-related illnesses including functional gastrointestinal disorders (FGIDs) and obesity are rapidly emerging health issues worldwide. Research has focused on addressing FGIDs via in-person cognitive-behavioral therapies, diet modulat
Externí odkaz:
https://doaj.org/article/097a466f0e964eacb1bdce26742f7e4e
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2482-2490 (2019)
Vedolizumab is a monoclonal antibody to the α4β7 integrin that selectively reduces intestinal lymphocyte trafficking, thereby providing a safe and effective treatment option for patients with inflammatory bowel disease (IBD). This product review ou
Externí odkaz:
https://doaj.org/article/5375fc85c13d434c820dccc6752b36d7
Autor:
Emily C. L. Wong, Shahin Merat, Cristina Monaco, Parambir S. Dulai, Vipul Jairath, John K. Marshall, Walter Reinisch, Neeraj Narula
Publikováno v:
Digestive Diseases and Sciences. 68:2635-2646